Clinigen has signed exclusive agreements with Mitsubishi Tanabe, Shionogi and Romark to cooperate on expanded access to their medicines.

Veristat finished enrollment for a study sponsored by AOBiome earlier, and that earned it a preferred provider agreement.

Six years after Pfizer's landmark REMOTE trial, Parexel and Sanofi are revisiting the idea of using wearables in clinical trials.

Probably hoping to help turn things around after clinical setbacks, microRNA biotech Regulus tapped the help of CRO Aptuit.

SynteractHCR will leverage the GOG Foundation's network of 300 investigational sites to support gynecologic oncology studies.

Medical device-focused CRO Genae has invested an undisclosed amount in Meditrix, a Japanese CRO in that same field, and obtained a call option to acquire the…

Charles River Laboratories has beefed up its library of patient-derived xenografts (PDXs) by adding new genetic characteristics into the mix.

DelMar is advancing its first-in-class brain cancer med dianhydrogalactitol (VAL-083) into phase 3, and it has recruited PRA Health Sciences to conduct that…

Quintiles and IMS Health came together last year in a massive $19 billion megamerger, and now INC and inVentiv are looking to follow suit, combining into one…

Partnering